Close
Publications
It was agreed that any research that CONVINCE generates is based on a prior consensus of all members of the CONVINCE Scientific Committee.听
听
Gregor Liegl, Felix H. Fischer, Bernard Canaud, Mark Woodward, Claudia Barth, Andrew Davenport,听Marietta T枚r枚k,听 Giovanni F. M. Strippoli, J枚rgen Hegbrant,听 Krister Cromm, Michiel L. Bots,听Peter J. Blankestijn,听 Kathrin I. Fischer, Matthias Rose on behalf of the CONVINCE Scientific Committee. Using a measurement type鈥慽ndependent metric to compare patterns of determinants between patient鈥憆eported versus performance鈥慴ased physical function in hemodialysis patients. Quality of Life Research 2024听听
Matthias Rose, Felix H. Fischer, Gregor Liegl, Giovanni FM. Strippoli, Carina Hockham, Robin WM. Vernooij, Claudia Barth, Bernard Canaud, Adrian Covic, Krister Cromm, Andrea M. Cucui, Andrew Davenport, Kathrin I. Fischer, J枚rgen Hegbrant, Hanna Jaha, Anna Schappert, Marietta T枚r枚k, Mark Woodward, Michiel L. Bots, Peter J. Blankestijn, for the CONVINCE Scientific Committee and CONVINCE Investigators.听The CONVINCE randomized trial found positive effects on quality of life for patients with chronic kidney disease treated with hemodiafiltration. Kidney International听2024 Jul 30:S0085-2538(24)00534-9.听听
Vernooij RWM, Hockham, C, Barth C, Canaud B, Cromm K, Davenport A, Hegbrant J, Rose M, Strippoli GFM, T枚r枚k听M, Woodward M, Bots ML, Blankestijn PJ.;听High-target haemodiafiltration convective dose achieved in the majority of patients in a 6-month intermediary analysis of the CONVINCE randomised controlled trial.听 Kidney International Reports 2023 Vol 8(11) p. 2276-2283.听听听听
Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli G, Canaud B, Hegbrant J, Barth C, Covic A, Cromm K, Cucui A, Davenport A, Rose M,听T枚r枚k听M, Woodward M, Bots ML听for the听CONVINCE Scientific Committee Investigators.听 Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure. New England Journal of Medicine 2023, 389 p.700-709听听
Liegl G, Fischer FH, Woodward M, T枚r枚k M, Strippoli GFM, Hegbrant J, Davenport A, Cromm K, Canaud B, Bots ML, Blankestijn PJ, Barth C, Fischer KI, Rose M; CONVINCE Scientific Committee. Physical Performance tasks were linked to the PROMIS physical function metric in patients undergoing hemodialysis.听 J. Clin Epidemiol. 2023 Vol 159, p. 128-138.听听
van Kruijsdijk RCM, Vernooij听RWM, Bots ML,听Peters听SAE, Dorresteijn JAN,听 Visseren听FLJ,听Blankestijn PJ, Debray,TPA,听The HDF Pooling Project investigators.听 Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction,听Clinical Kidney Journal 2022; 15(10); 1924-1931.听
Vernooij听RWM, Bots听ML, Strippoli GFM, Canaud B, Cromm K, Woodward M, Blankestijn, PJ听听听Nephrol Dial Transplant 2022 37(6): 1006-1013.听 doi: .听
Davenport A.听听.听 Gerontol Geriatr Med. 2022听 Mar 28;8:23337214221085875. doi: eCollection 2022 Jan-Dec.听
Blankestijn听PJ,听Fischer听KI, Barth听C, Cromm K, Canaud听B, Davenport A, Grobbee DE, Hegbrant J, Roes KC, Rose听M, Strippoli GF, Vernooij RW, Woodward M, de Wit GA, Bots ML.听BMJ OPEN, 2020, 10 (2), doi:10.1136/bmjopen-2019-033228
Blankestijn PJ, Grooteman MP,听Nube MJ听and Bots ML. .听 Nephrology Dialysis Transplantation听 2018, 33, iii53-iii58. doi: 10.1093/ndt/gfy218.听
听
Meeting Presentations
Kathrin I. Fischer, Peter J. Blankestijn, Krister Cromm, Michiel L. Bots, Claudia Barth, Bernard Canaud, J枚rgen Hegbrant, Giovanni Strippoli, Andrew Davenport, Mark Woodward, Matthias Rose on behalf of the CONVINCE Consortium.听听Assessing the Patient鈥檚 Perspective in End-stage Kidney Disease 鈥揂Domain-Guided Approach Applied in the CONVINCE Trial. Poster presentation at 26th Annual Conference ISOQOL, 2019.听
Fischer KI, Blankestijn PJ, Cromm K, Bots ML, Barth C, Canaud B, Hegbrant J, Mac谩rio F, Marr贸n B, T枚r枚k M, Davenport A, Lee MM, Strippoli GFM, Wohn L, Woodward M, Rose M. Assessment of generic and dialysis-related fatigue 鈥� Identification of individual trajectories and investigation of ecological validity. Quality of Life Research. 2020;29(S1): S180.听听听 听听link to abstract.听 Poster presentation at 27th Annual Conference ISOQOL, 2020.
Robin W.M. Vernooij, on behalf of the CONVINCE Study Group 鈥淭he comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) study鈥� presentation at the 58th ERA-EDTA Congress in Berlin, June 2021.听 Nephrology Dialysis Transplantation, Volume 36, Issue Supplement_1, May 2021, gfab098.004,听
Gregor Liegl, Felix H. Fischer, Peter J. Blankestijn, Krister Cromm, Michiel L. Bots, Matthias Rose, on behalf of the CONVINCE Scientific Committee, Can patient-reported and performance outcome measures be used to assess a common construct of general physical function in patients undergoing hemodialysis? Oral presentation at the ISOQOL 2022 Prague.
Le Hong Ngoc Pham, Krister Cromm, Yan Zhang, Anna Schappert, Gregor Liegl, Kathrin I. Fischer, Felix Fischer and Matthias Rose. Psychometric validation of the CONVINCE inter- & intradialytic symptoms questionnaire.听 American Society of Nephrology听 Accepted as poster presentation at the 56th Annual Meeting of the American Society of Nephrology in Pennsylvania USA 1-5 November 2023.
Krister Cromm, Le Hong Ngoc Pham, Hanna Jaha, Anna Schappert, Gregor Liegl, Kathrin I. Fischer, Felix Fischer, Matthias Rose. Self-Efficacy and Social Support Determine Self-Reported Health in hemodialysis patients. Accepted as oral presentation at the 56th Annual Meeting of the American Society of Nephrology in Pennsylvania USA 1-5 November 2023.
Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli GFM, Barth C, Canaud B, Covic A, Cromm K, Cucui AM, Davenport A, Hegbrant J, Rose M, Sanchez Torres D, T枚r枚k M, Woodward M, Bots ML, for the CONVINCE Scientific Committee and CONVINCE Investigators.听 CONVINCE: Haemodiafiltration versus haemodialysis for mortality, cardiovascular events, and hospitalisation in adult patients.听 ERA 2023.
Krister Cromm, Le Hong Ngoc Pham, Hanna Jaha, Anna Schappert, Gregor Liegl, Felix Fischer, Matthias Rose. Self-Efficacy Explains Health-Related Quality of Life on Dialysis more than Social Support, Medical and Demographic Patient Characteristics. ISOQOL 2023, Calgary, Canada.听
听
听